Mizuho Reiterates Buy on Tenet Healthcare, Raises Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has reiterated a Buy rating on Tenet Healthcare (NYSE:THC) and increased the price target from $118 to $130, signaling confidence in the company's future performance.
May 01, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Ann Hynes reiterates a Buy rating on Tenet Healthcare and raises the price target from $118 to $130.
The reiteration of a Buy rating combined with an increased price target usually signals analyst confidence in the company's future performance and growth prospects. This can positively influence investor sentiment and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100